SAN FRANCISCO — In a landmark settlement agreement, two major pharmaceutical companies and a retailer will pay San Francisco over $267 million in the next 15 years to resolve allegations they were complicit in fueling the city's opioid crisis.
The three companies have agreed to pay a collected $267 million in settlement fees for a 2018 lawsuit, with Walgreens taking the largest share at a whopping $229,610,002. Each of the three settlement agreements mandates a special fund where the proceeds will be deposited, and each will have slightly different eligible use requirements, said City Controller Ben Rosenfield. He added that the city will receive much larger payments in the early years of the settlement.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: